Inventor
FARAND JULIE
US19 patents
⚠️ This page may combine multiple inventors who share the name “FARAND JULIE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GILEAD SCIENCES INC
14 patentsUS11787825B2Oct 17, 2023
Therapeutic compounds for HIV virus infection
GILEAD SCIENCES INC14 citations93
US11584738B2Feb 21, 2023
LPA receptor antagonists and uses thereof
GILEAD SCIENCES INC11 citations84
US12084467B2Sep 10, 2024
Therapeutic compounds for HIV virus infection
GILEAD SCIENCES INC7 citations83
US9376441B2Jun 28, 2016
Substituted pyrrolidines as SYK inhibitors
GILEAD SCIENCES INC17 citations82
US11247986B2Feb 15, 2022
FXR (NR1H4) modulating compounds
GILEAD SCIENCES INC1 citations73
US10329286B2Jun 25, 2019
FXR (NR1H4) modulating compounds
GILEAD SCIENCES INC1 citations73
US11912686B2Feb 27, 2024
LPA receptor antagonists and uses thereof
GILEAD SCIENCES INC3 citations72
US10005774B2Jun 26, 2018
Syk inhibitors
GILEAD SCIENCES INC4 citations72
US11548871B2Jan 10, 2023
Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereof
GILEAD SCIENCES INC3 citations71
US12404262B2Sep 2, 2025
Therapeutic compounds for HIV virus infection
GILEAD SCIENCES INC1 citations63
US12358903B2Jul 15, 2025
FXR (NR1H4) modulating compounds
GILEAD SCIENCES INC0 citations62
US12187753B2Jan 7, 2025
Therapeutics compounds for HIV virus infection
GILEAD SCIENCES INC0 citations61
US11999717B2Jun 4, 2024
Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereof
GILEAD SCIENCES INC0 citations61
US12503454B2Dec 23, 2025
LPA receptor antagonists and uses thereof
GILEAD SCIENCES INC0 citations50